Nanoparticles coated with fragments of the body's own proteins are shown to induce T cells of the immune system to adopt regulatory functions that suppress autoimmune reactions involving these self-antigens. See Article p.434
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
Clinical Reviews in Allergy & Immunology Open Access 02 July 2016
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Clemente-Casares, X. et al. Nature 530, 434–440 (2016).
Noon, L. Lancet i, 1572–1573 (1911).
Larché, M. & Wraith, D. C. Nature Med. 11, S69–S76 (2005).
Lafferty, K. J. & Cunningham, A. J. Aust. J. Exp. Biol. Med. Sci. 53, 27–42 (1975).
Baxter, A. G. & Hodgkin, P. D. Nature Rev. Immunol. 2, 439–446 (2002).
Schwartz, R. H. Annu. Rev. Immunol. 21, 305–334 (2003).
O'Garra, A., Vieira, P. L., Vieira, P. & Goldfeld, A. E. J. Clin. Invest. 114, 1372–1378 (2004).
Trinchieri, G. J. Exp. Med. 204, 239–243 (2007).
Sabatos-Peyton, C. A., Verhagen, J. & Wraith, D. C. Curr. Opin. Immunol. 22, 609–615 (2010).
Gabryšová, L. et al. J. Exp. Med. 206, 1755–1767 (2009).
Burton, B. R. et al. Nature Commun. 5, 4741 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares competing financial interests. See go.nature.com/ukjrkv for details.
Related links
Rights and permissions
About this article
Cite this article
Wraith, D. Antigen-specific immunotherapy. Nature 530, 422–423 (2016). https://doi.org/10.1038/nature17300
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature17300
This article is cited by
-
An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis
Nature Biomedical Engineering (2023)
-
Membranous nephropathy
Nature Reviews Disease Primers (2021)
-
Celgene eyes 'inverse vaccines' in Anokion and Delinia deals
Nature Biotechnology (2017)
-
Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
Clinical Reviews in Allergy & Immunology (2017)